SEC Form 4 · accession 0000898432-19-000377
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Johnson
Officer — Exec. VP of WW Sales and Mktg
Period of report
Mar 11, 2019
Accepted (ET)
Mar 13, 2019 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 11, 2019 | A | 17,033 | $0.93 | A | 18,401 | D | |
| Common StockF1 | Mar 11, 2019 | S | 17,033 | $25.38 | D | 1,368 | D | |
| Common Stock | Mar 12, 2019 | A | 3,658 | $0.93 | A | 5,026 | D | |
| Common StockF2 | Mar 12, 2019 | S | 3,658 | $25.0033 | D | 1,368 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $0.93 | Mar 11, 2019 | M | 17,033 | D | — | Dec 27, 2021 | Common Stock | 17,033 | 296,596 | D |
| Stock Option (Right to Buy)F4 | $0.93 | Mar 12, 2019 | M | 3,658 | D | — | Dec 27, 2021 | Common Stock | 3,658 | 292,938 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $25.0 to $26.125. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $25.0 to $25.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
- F4This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.